The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89bio Inc | EQUITIES | 282559103 | 6,674,014 | 438,215 | SH | SOLE | 438,215 | 0 | 0 | ||
89bio, Inc | LONG OPTION CALLS | 282559103 | 3,046,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
Aclaris Therapeutics Inc | EQUITIES | 00461U105 | 1,780,609 | 220,100 | SH | SOLE | 220,100 | 0 | 0 | ||
Aclaris Therapeutics, Inc | LONG OPTION CALLS | 00461U105 | 5,269,826 | 651,400 | SH | Call | SOLE | 651,400 | 0 | 0 | |
Acumen Pharmaceuticals Inc | EQUITIES | 00509G209 | 596,503 | 146,922 | SH | SOLE | 146,922 | 0 | 0 | ||
Akero Therapeutics Inc | EQUITIES | 00973Y108 | 7,749,984 | 202,561 | SH | SOLE | 202,561 | 0 | 0 | ||
Aligos Therapeutics Inc | EQUITIES | 01626L105 | 552,269 | 631,887 | SH | SOLE | 631,887 | 0 | 0 | ||
Allakos Inc | EQUITIES | 01671P100 | 938,995 | 211,010 | SH | SOLE | 211,010 | 0 | 0 | ||
Alnylam Pharmaceuticals Inc | EQUITIES | 02043Q107 | 2,813,094 | 14,043 | SH | SOLE | 14,043 | 0 | 0 | ||
Altimmune, Inc | LONG OPTION CALLS | 02155H200 | 1,754,254 | 415,700 | SH | Call | SOLE | 415,700 | 0 | 0 | |
Astria Therapeutics Inc | EQUITIES | 04635X102 | 1,247,846 | 93,823 | SH | SOLE | 93,823 | 0 | 0 | ||
Bellus Health Inc | EQUITIES | 07987C204 | 7,200,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
BioCryst Pharmaceuticals Inc | EQUITIES | 09058V103 | 4,818,493 | 577,757 | SH | SOLE | 577,757 | 0 | 0 | ||
Biogen Idec Inc | EQUITIES | 09062X103 | 3,144,797 | 11,311 | SH | SOLE | 11,311 | 0 | 0 | ||
Bridgebio Pharma Inc | EQUITIES | 10806X102 | 663,200 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
Celldex Therapeutics Inc | EQUITIES | 15117B202 | 3,045,743 | 84,651 | SH | SOLE | 84,651 | 0 | 0 | ||
Cerus Corp | EQUITIES | 157085101 | 3,424,119 | 1,152,902 | SH | SOLE | 1,152,902 | 0 | 0 | ||
Cogent Biosciences Inc | EQUITIES | 19240Q201 | 6,250,259 | 579,264 | SH | SOLE | 579,264 | 0 | 0 | ||
Compugen Ltd | EQUITIES | M25722105 | 231,792 | 330,188 | SH | SOLE | 330,188 | 0 | 0 | ||
Cue Biopharma Inc | EQUITIES | 22978P106 | 1,093,412 | 306,278 | SH | SOLE | 306,278 | 0 | 0 | ||
Cullinan Oncology Inc | EQUITIES | 230031106 | 2,711,277 | 265,032 | SH | SOLE | 265,032 | 0 | 0 | ||
Cvrx Inc | EQUITIES | 126638105 | 279,600 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
Eliem Therapeutics Inc | EQUITIES | 28658R106 | 1,409,270 | 485,955 | SH | SOLE | 485,955 | 0 | 0 | ||
Eloxx Pharmaceuticals Inc | EQUITIES | 29014R202 | 135,728 | 54,075 | SH | SOLE | 54,075 | 0 | 0 | ||
Fresh Tracks Therapeutics Inc | EQUITIES | 10802T204 | 6,600 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
Gilead Sciences Inc | EQUITIES | 375558103 | 4,988,986 | 60,130 | SH | SOLE | 60,130 | 0 | 0 | ||
Immatics Nv | EQUITIES | N44445109 | 1,948,781 | 282,432 | SH | SOLE | 282,432 | 0 | 0 | ||
ImmunoGen Inc | EQUITIES | 45253H101 | 576,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ImmunoGen, Inc | LONG OPTION CALLS | 45253H101 | 4,332,288 | 1,128,200 | SH | Call | SOLE | 1,128,200 | 0 | 0 | |
Incyte Corp | EQUITIES | 45337C102 | 2,452,699 | 33,938 | SH | SOLE | 33,938 | 0 | 0 | ||
Insmed Inc | EQUITIES | 457669307 | 2,451,688 | 143,794 | SH | SOLE | 143,794 | 0 | 0 | ||
Intellia Therapeutics Inc | EQUITIES | 45826J105 | 1,410,968 | 37,858 | SH | SOLE | 37,858 | 0 | 0 | ||
Intra-Cellular Therapies Inc | EQUITIES | 46116X101 | 6,770,645 | 125,035 | SH | SOLE | 125,035 | 0 | 0 | ||
Jasper Therapeutics Inc | EQUITIES | 471871103 | 905,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KalVista Pharmaceuticals Inc | EQUITIES | 483497103 | 5,687,056 | 723,544 | SH | SOLE | 723,544 | 0 | 0 | ||
Karyopharm Therapeutics Inc | EQUITIES | 48576U106 | 5,996,147 | 1,541,426 | SH | SOLE | 1,541,426 | 0 | 0 | ||
Krystal Biotech Inc | EQUITIES | 501147102 | 2,723,161 | 34,014 | SH | SOLE | 34,014 | 0 | 0 | ||
LAVA Therapeutics NV | EQUITIES | N51517105 | 232,883 | 140,291 | SH | SOLE | 140,291 | 0 | 0 | ||
MacroGenics Inc | EQUITIES | 556099109 | 9,764,171 | 1,361,809 | SH | SOLE | 1,361,809 | 0 | 0 | ||
Madrigal Pharmaceuticals Inc | EQUITIES | 558868105 | 2,422,600 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
Mersana Therapeutics Inc | EQUITIES | 59045L106 | 2,219,642 | 540,059 | SH | SOLE | 540,059 | 0 | 0 | ||
Merus NV | EQUITIES | N5749R100 | 12,305,626 | 668,784 | SH | SOLE | 668,784 | 0 | 0 | ||
Mirum Pharmaceuticals Inc | EQUITIES | 604749101 | 2,544,655 | 105,939 | SH | SOLE | 105,939 | 0 | 0 | ||
Monte Rosa Therapeutics Inc | EQUITIES | 61225M102 | 242,705 | 31,156 | SH | SOLE | 31,156 | 0 | 0 | ||
MoonLake Immunotherapeutics | EQUITIES | 61559X104 | 2,261,993 | 105,750 | SH | SOLE | 105,750 | 0 | 0 | ||
Morphic Holding Inc | EQUITIES | 61775R105 | 1,945,386 | 51,684 | SH | SOLE | 51,684 | 0 | 0 | ||
Nuvalent Inc | EQUITIES | 670703107 | 7,345,196 | 281,533 | SH | SOLE | 281,533 | 0 | 0 | ||
Oric Pharmaceuticals Inc | EQUITIES | 68622P109 | 8,184,887 | 1,435,945 | SH | SOLE | 1,435,945 | 0 | 0 | ||
Pharvaris NV | EQUITIES | N69605108 | 4,505,862 | 559,387 | SH | SOLE | 559,387 | 0 | 0 | ||
Phathom Pharmaceuticals Inc | EQUITIES | 71722W107 | 1,428,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Pliant Therapeutics Inc | EQUITIES | 729139105 | 2,660,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Pliant Therapeutics, Inc | LONG OPTION CALLS | 729139105 | 5,309,360 | 199,600 | SH | Call | SOLE | 199,600 | 0 | 0 | |
Point Biopharma Global Inc | EQUITIES | 730541109 | 1,442,928 | 198,477 | SH | SOLE | 198,477 | 0 | 0 | ||
Poseida Therapeutics Inc | EQUITIES | 73730P108 | 8,283,047 | 2,689,301 | SH | SOLE | 2,689,301 | 0 | 0 | ||
Prometheus Biosciences Inc | EQUITIES | 74349U108 | 1,494,002 | 13,921 | SH | SOLE | 13,921 | 0 | 0 | ||
Protagonist Therapeutics Inc | EQUITIES | 74366E102 | 2,426,178 | 105,486 | SH | SOLE | 105,486 | 0 | 0 | ||
Regeneron Pharmaceuticals Inc | EQUITIES | 75886F107 | 4,108,350 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | WARRANTS | 77313F114 | 11,531 | 104,828 | SH | SOLE | 104,828 | 0 | 0 | ||
Sarepta Therapeutics Inc | EQUITIES | 803607100 | 1,277,684 | 9,270 | SH | SOLE | 9,270 | 0 | 0 | ||
Schrodinger Inc | EQUITIES | 80810D103 | 5,603,682 | 212,825 | SH | SOLE | 212,825 | 0 | 0 | ||
Seres Therapeutics Inc | EQUITIES | 81750R102 | 1,318,417 | 232,525 | SH | SOLE | 232,525 | 0 | 0 | ||
Tela Bio Inc | EQUITIES | 872381108 | 575,581 | 54,096 | SH | SOLE | 54,096 | 0 | 0 | ||
Terns Pharmaceuticals Inc | EQUITIES | 880881107 | 7,908,196 | 667,922 | SH | SOLE | 667,922 | 0 | 0 | ||
Trevi Therapeutics Inc | EQUITIES | 89532M101 | 1,638,959 | 885,924 | SH | SOLE | 885,924 | 0 | 0 | ||
United Therapeutics Corp | EQUITIES | 91307C102 | 4,160,729 | 18,578 | SH | SOLE | 18,578 | 0 | 0 | ||
Ventyx Biosciences Inc | EQUITIES | 92332V107 | 2,345,000 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
Veracyte Inc | EQUITIES | 92337F107 | 4,675,262 | 209,653 | SH | SOLE | 209,653 | 0 | 0 | ||
Vertex Pharmaceuticals Inc | EQUITIES | 92532F100 | 4,152,938 | 13,181 | SH | SOLE | 13,181 | 0 | 0 | ||
Viewray Inc | EQUITIES | 92672L107 | 9,666,368 | 2,793,748 | SH | SOLE | 2,793,748 | 0 | 0 | ||
Viking Therapeutics Inc | EQUITIES | 92686J106 | 6,327,000 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | ||
Viridian Therapeutics Inc | EQUITIES | 92790C104 | 925,533 | 36,381 | SH | SOLE | 36,381 | 0 | 0 | ||
Xenon Pharmaceuticals Inc | EQUITIES | 98420N105 | 3,458,853 | 96,643 | SH | SOLE | 96,643 | 0 | 0 |